Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v7-FR
Language English French
Date Updated 2022-12-01 2022-11-14
Drug Identification Number 00496480 00496480
Brand name TEVA-PROPRANOLOL TEVA-PROPRANOLOL
Common or Proper name TEVA-PROPRANOLOL TEVA-PROPRANOLOL
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100,1000 100,1000
ATC code C07AA C07AA
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-22 2022-09-22
Estimated end date 2022-12-20 2023-01-10
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments